Treatment of hepatitis B virus cirrhosis

about

Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: results of an Iranian nationwide study.

P2860

Q43777564-EB66D150-E8FF-4BA9-8167-6D2BC29FE9A3

P2860

Treatment of hepatitis B virus cirrhosis

Item

http://www.wikidata.org/entity/Q42224748

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Treatment of hepatitis B virus cirrhosis

@en

Treatment of hepatitis B virus cirrhosis

@nl

type

Item

label

Treatment of hepatitis B virus cirrhosis

@en

Treatment of hepatitis B virus cirrhosis

@nl

prefLabel

Treatment of hepatitis B virus cirrhosis

@en

Treatment of hepatitis B virus cirrhosis

@nl

P1476

Treatment of hepatitis B virus cirrhosis

@en

P2093

Mario Rizzetto

http://www.w3.org/2001/XMLSchema#string

P2860

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir.

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis.

Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis.

Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function.

P304

309-311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.5812/HEPATMON.6113

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229072689

http://www.w3.org/2001/XMLSchema#string

P698

22783340

http://www.w3.org/2001/XMLSchema#string

P932

3389354

http://www.w3.org/2001/XMLSchema#string

Treatment of hepatitis B virus cirrhosis

about

P2860

P2860

Treatment of hepatitis B virus cirrhosis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932